19/11 2025 Redsense releases BioStock CEO interview following Q3 2025 report Halmstad, Sweden, November 19, 2025 – Redsense Medical AB (publ) (“Redsense'' or “the Company”) announces that a video interview with CEO Sebastien Bollue has been… [read more]
19/11 2025 Interim Report Q3 – July – September, 2025 Redsense Medical AB (publ.) July – September 2025 · Net sales amounted to kSEK 6,935 (5,030). · Operating loss, EBIT amounted to kSEK -428 (-3,272). · Excl. Exchange rate… [read more]
18/11 2025 Redsense initiates pilot study with a global leading dialysis provider in Germany Halmstad, Sweden, November 18, 2025 – Redsense Medical AB (publ) (“Redsense'' or “the Company”) today announces that the Company will conduct a pilot study in… [read more]